Cipla posted a consolidated net profit of Rs 789 crore for the fiscal first quarter, down 39 percent from that a year ago. The earnings also fell behind analysts' estimates.Cipla Ltd reported a weaker-than-expected results for the first quarter of FY27, with net profit falling 39 percent year-on-year and missing Street estimates, while revenue growth remained modest and operating margins contracte...

The Nifty Pharma index fell nearly 2 percent to emerge as the worst-performing sectoral index in early trade on Wednesday, with heavyweight drugmakers Sun Pharma, Cipla and Dr Reddy's Laboratories featuring among the top losers on the Nifty 50 after US President Donald Trump unveiled a phased tariff plan for imported generic medicines. The tariff announcement raised concerns over the long-term out...

Pharmaceutical stocks emerged as the strongest pocket of the market on Tuesday, accounting for the top three gainers on the Nifty 50 and dominating the BSE Midcap top gainers list. The Nifty Pharma index rose nearly 2 percent, even as benchmark indices traded largely flat in early deals.At 09:39 hrs IST, the Nifty Pharma index was up 1.88 percent, making it the best-performing sectoral index on th...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, appointments, and order wins, here’s a quick look at which stocks will be in focus in today's trade:Results TodayBillionbrains Garage Ventures GROWW, Bank of Maharashtra, PNB Housing Finance, SML Mahindra, Nelco, PNB Gilts, Ugro Capital, Indosolar, Indbank Merchant Banking Se...

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, and restructurings, here’s a quick look at which stocks will be in focus in today's trade:Results TodayBF Utilities, PVP Ventures, Stovec Industries, and Kome-On Communication will release their quarterly earnings today.Stocks to WatchUPLThe Board has approved a group reorganisation ...